Administrative & Regulatory

Administrative agencies and changes in the area of regulatory law, are two areas of law which are regularly covered in the news media. And, because these areas of law change frequently, it is important to have the latest news which is available. The National Law Review covers the latest administrative and regulatory actions as they unfold. From appointment of new Administrative law judges (ALJs), to the appointment of the Officer of Management and Budget office in Mick Mulvaney, the National Law Review covers this, and other agency and regulatory news as it unfolds.

New regulations in tax-law, rulemaking decisions, the Securities and Exchange Commission (SEC), and the latest news in regulatory agendas, are reported on daily on NLR’s website. The adjudication and enforcement of regulatory agendas, new appointments to government offices and agencies, and news from the federal and state-level, is updated on the National Law Review daily. Readers can find information about new legislation, law-making, changes in government agencies, the appointment of new directors, and litigation involving administrative and regulatory news as it unfolds.

Anything encompassing new government regulations will also be found under the administrative and regulatory law section on The National Law Review. Regulations made by government agencies via the powers appointed to them by statutes or the Constitution are highly covered topics on the National Law Review as well. For visitors who want the latest information on the new administration which is heading the CFPB, to reading about new state regulations where they live, will find such topics covered on NLR.

Because news is unfolding on a regular basis, visitors want to read about the latest topics, areas of concern, and rulemaking which might affect them in the future. The National Law Review adds new content on a daily basis, meaning visitors will always have up-to-date legal analysis on regulations that may impact their business.

 

For hourly updates on the latest in legal, legislation, government regulation, and corporate law news, be sure to follow the National Law Review Twitter feed, and sign up for complimentary e-news bulletins.

 

Custom text Title Organization
Apr
12
2024
 FDA Charts Course for Regulating AI Used in Medical Products McDermott Will & Emery
Jun
6
2023
 FDA Clarifies Approach to Pediatric Drug Development Sheppard, Mullin, Richter & Hampton LLP
Jan
13
2021
 FDA Clarifies Food Traceability List Descriptions and Publishes Related FAQ Keller and Heckman LLP
Jan
24
2022
 FDA Clarifies Labeling Rules for Quantitative Claims About Sugar Keller and Heckman LLP
Oct
5
2018
 FDA Collects Thousands of Pages of Documents in Inspection of JUUL Labs Keller and Heckman LLP
Apr
3
2019
 FDA Commissioner Gottlieb Says Agency Will Not Tolerate Deceptive Marketing of CBD Products; Issues Warning Letters Epstein Becker & Green, P.C.
Mar
15
2019
 FDA Commissioner Releases Statement On Biotechnology Innovations Bergeson & Campbell, P.C.
Mar
6
2019
 FDA Commissioner Scott Gottlieb Resigns Keller and Heckman LLP
Mar
11
2020
 FDA Commissioner Signals Enforcement Policy, Advancement of Research for CBD Products Sheppard, Mullin, Richter & Hampton LLP
Nov
17
2022
 FDA Completes First Pre-Market Consultation for Human Food made using Animal Cell Culture Technology Keller and Heckman LLP
Dec
9
2021
 FDA Completes Peanut Allergy Health Claim Review Keller and Heckman LLP
Apr
11
2022
 FDA Completes Review of GE Canola Seeds After Response to Last Year’s Inadvertent Release Keller and Heckman LLP
Oct
3
2022
 FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Jan
27
2023
 FDA Concludes that New Regulatory Frameworks for Foods and Supplements Containing Cannabidiol are Needed, Will Work with Congress Keller and Heckman LLP
Apr
4
2022
 FDA Confirms N-acetyl-L-cysteine (NAC) is Excluded From the Dietary Supplement Definition and Leaves Open Potential Rulemaking to Allow the use of NAC in Dietary Supplements Keller and Heckman LLP
Mar
24
2020
 FDA Confirms That At-Home Collection Kits Are Not Authorized for Use with COVID-19 Tests Epstein Becker & Green, P.C.
May
24
2021
 FDA Continues Enforcement Action Against Kratom Keller and Heckman LLP
Apr
22
2020
 FDA Continues Its Diverse Agency Actions in Response to COVID-19 Pandemic Mintz
Apr
2
2021
 FDA Continues to Referee the CBD Market Dinsmore & Shohl LLP
Apr
24
2024
 FDA Continues to Take Stance That it Will Not Issue CBD Rules Foley & Lardner LLP
Oct
26
2021
 FDA Convenes Medical Device Workshop Focused on Artificial Intelligence and Machine Learning Transparency Nelson Mullins
Jun
4
2023
 FDA Cracking Down on Unapproved HCT/Ps with Fourth Untitled Letter of 2023 Sheppard, Mullin, Richter & Hampton LLP
May
9
2022
 FDA Cracks Down on Unauthorized and Counterfeit COVID-19 Diagnostic Tests Mintz
Nov
14
2023
 FDA Delays Enforcement of Cosmetic Facility Registration and Product Listing Requirements ArentFox Schiff LLP
Nov
16
2023
 FDA Delays Enforcement of Cosmetic Product Facility Registration and Listing Requirements Greenberg Traurig, LLP
Nov
22
2023
 FDA Delays Enforcement of MOCRA Deadlines for Facility Registration and Product Listing to July 1, 2024 Squire Patton Boggs (US) LLP
Aug
8
2022
 FDA Delays Enforcement of UDI Reporting Requirements for Consumer Health Products Sheppard, Mullin, Richter & Hampton LLP
Jun
24
2022
 FDA Denies Authorization to Market JUUL ENDS Products; Company Intends to Seek Stay of the Marketing Denial Orders Keller and Heckman LLP
Jul
28
2014
 FDA Denies Citizen Petition’s Request to Ban Marketing of Non-Absorbable Surgical Mesh Products for Transvaginal Repair of Pelvic Organ Prolapse Covington & Burling LLP
May
7
2019
 FDA Denies Request for Public Hearing on Perchlorate Keller and Heckman LLP
May
24
2022
 FDA Denies Request to Exempt D-Tagatose from Added Sugar Labeling Keller and Heckman LLP
Jul
27
2023
 FDA Denies Request to Reconsider Petition on Phthalates in Food Packaging Keller and Heckman LLP
Oct
23
2023
 FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework Keller and Heckman LLP
Jun
8
2020
 FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD Keller and Heckman LLP
Mar
27
2012
 FDA Discloses Method for Classifying Food Facilities as "High Risk" Under FSMA Barnes & Thornburg LLP
Subscribe to Administrative & Regulatory
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins